Mammalian alphaherpesvirus miRNAs

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1809, Issue 11-12, 2011, Pages 641-653

  Jurak, Igor ^a   Griffiths, Anthony ^b   Coen, Donald M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Herpes B virus; Herpes simplex virus; Latency; Mammalian alphaherpesviruses; miRNAs; Varicella zoster virus

Indexed keywords

MICRORNA;

ALPHAHERPESVIRINAE; BOVINE HERPES VIRUS; GENE EXPRESSION REGULATION; GENE LOCATION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; LATENT VIRUS INFECTION; MACACINE HERPESVIRUS 1; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PSEUDORABIES HERPETOVIRUS; REVIEW; RNA ANALYSIS; VARICELLA ZOSTER VIRUS; VIRUS GENOME; VIRUS LATENCY; VIRUS REPLICATION;

ALPHAHERPESVIRINAE; ANIMALS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 3, HUMAN; HUMANS; MICRORNAS; VIRUS LATENCY;

BOVINE HERPESVIRUS 1; CERCOPITHECINE HERPESVIRUS 1; HUMAN HERPESVIRUS 3; MAMMALIA; SIMPLEXVIRUS; SUID HERPESVIRUS 1;

EID: 80655127809     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2011.06.010     Document Type: Review

References (156)

1. Roizman B., Knipe D.M., Whitley R.J. Herpes simplex viruses. Fields Virology 2007, 2502-2601. Lippincott Williams & Wilkins, Philadelphia. Fifth Edition. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, S.E. Straus, M.A. Martin, B. Roizman (Eds.).
2. Davison A.J., Eberle R., Ehlers B., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E. The order Herpesvirales. Arch. Virol. 2009, 154:171-177.
3. McGeoch D.J., Dolan A., Ralph A.C. Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J. Virol. 2000, 74:10401-10406.
4. Mori I., Nishiyama Y. Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another?. Rev. Med. Virol. 2005, 15:393-406.
5. Cohen J.I., Straus S.E., Arvin A.M. Varicella-Zoster virus replication, pathogenesis, and management. Fields Virology 2007, Lippincott Williams & Wilkins, Philadelphia. Fifth Edition. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, S.E. Straus, M.A. Martin, B. Roizman (Eds.).
6. Bartel D.P. MicroRNAs: genomics, biogenesis mechanisms, and function. Cell 2004, 116:281-297.
7. Umbach J.L., Cullen B.R. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 2009, 23:1151-1164.
8. Lee Y., Jeon K., Lee J.T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 2002, 21:4663-4670.
9. Gregory R.I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
10. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
11. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
12. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001, 293:834-838.
13. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001, 15:188-200.
14. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., Hammond S.M., Joshua-Tor L., Hannon G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004, 305:1437-1441.
15. Liu J., Rivas F.V., Wohlschlegel J., Yates J.R., Parker R., Hannon G.J. A role for the P-body component GW182 in microRNA function. Nat. Cell Biol. 2005, 7:1261-1266.
16. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
17. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
18. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
19. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
20. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
21. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
22. Brennecke J., Stark A., Russell R.B., Cohen S.M. Principles of microRNA-target recognition. PLoS Biol. 2005, 3:e85.
23. McGeoch D.J., Cook S., Dolan A., Jamieson F.E., Telford E.A. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 1995, 247:443-458.
24. Pfeffer S., Sewer A., Lagos-Quintanta M., Sheridan R., Sander C., Grässer F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., Randall G., Lindenbach B.D., Rice C.M., Simon V., Ho D.D., Zavolan M., Tuschl T. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2:269-276.
25. Cui C., Griffiths A., Li G., Silva L.M., Kramer M.F., Gaasterland T., Wang X.J., Coen D.M. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 2006, 80:5499-5508.
26. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454:780-783.
27. Tang S., Bertke A.S., Patel A., Wang K., Cohen J.I., Krause P.R. An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10931-10936.
28. Tang S., Patel A., Krause P.R. Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. J. Virol. 2009, 83:1433-1442.
29. Besecker M.I., Harden M.E., Li G., Wang X.J., Griffiths A. Discovery of herpes B virus-encoded microRNAs. J. Virol. 2009, 83:3413-3416.
30. Jurak I., Kramer M.F., Mellor J.C., van Lint A.L., Roth F.P., Knipe D.M., Coen D.M. Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J. Virol. 2010, 84:4659-4672.
31. Umbach J.L., Nagel M.A., Cohrs R.J., Gilden D.H., Cullen B.R. Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J. Virol. 2009, 83:10677-10683.
32. Umbach J.L., Wang K., Tang S., Krause P.R., Mont E.K., Cohen J.I., Cullen B.R. Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2. J. Virol. 2010, 84:1189-1192.
33. Glazov E.A., Horwood P.F., Assavalapsakul W., Kongsuwan K., Mitchell R.W., Mitter N., Mahony T.J. Characterization of microRNAs encoded by the bovine herpesvirus 1 genome. J. Gen. Virol. 2010, 91:32-41.
34. Jaber T., Workman A., Jones C. Small noncoding RNAs encoded within the bovine herpesvirus 1 latency-related gene can reduce steady-state levels of infected cell protein 0 (bICP0). J. Virol. 2010, 84:6297-6307.
35. Anselmo A., Flori L., Jaffrezic F., Rutigliano T., Cecere M., Cortes-Perez N., Lefevre F., Rogel-Gaillard C., Giuffra E. Co-expression of host and viral microRNAs in porcine dendritic cells infected by the Pseudorabies virus. PLoS One 2011, 6:e17374.
36. Tobian A.A., Quinn T.C. Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention. Curr. Opin. HIV AIDS 2009, 4:294-299.
37. Kristie T.M., Roizman B. Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 alpha genes. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:71-75.
38. McKnight J.L., Kristie T.M., Roizman B. Binding of the virion protein mediating alpha gene induction in herpes simplex virus 1-infected cells to its cis site requires cellular proteins. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:7061-7065.
39. Kristie T.M., Roizman B. Differentiation and DNA contact points of host proteins binding at the cis site for virion-mediated induction of alpha genes of herpes simplex virus 1. J. Virol. 1988, 62:1145-1157.
40. Clements J.B., Watson R.J., Wilkie N.M. Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome. Cell 1977, 12:275-285.
41. Preston C.M. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild type virus or the temperature sensitive mutant tsK. J. Virol. 1979, 29:275-284.
42. Watson R.J., Clements J.B. A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature 1980, 285:329-330.
43. Godowski P.J., Knipe D.M. Identification of a herpes simplex virus function that represses late gene expression from parental viral genomes. J. Virol. 1985, 55:357-365.
44. Carrozza M., DeLuca N. Interactions of the viral activator protein ICP4 with TFIID through TAF250. Mol. Cell. Biol. 1996, 16:3085-3093.
45. Faber S.W., Wilcox K.W. Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA. Nuclei Acids Res. 1986, 14:6067-6083.
46. Everett R.D. Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 1984, 3:3135-3141.
47. Nabel G.J., Rice S.A., Knipe D.M., Baltimore D. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 1988, 239:1299-1302.
48. Gelman I.H., Silverstein S. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:256-260.
49. O'Hare P., Hayward G.S. Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J. Virol. 1985, 53:751-760.
50. Quinlan M.P., Knipe D.M. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol. Cell. Biol. 1985, 5:957-963.
51. Hagglund R., Roizman B. Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J. Virol. 2004, 78:2169-2178.
52. Roizman B., Gu H., Mandel G. The first 30minutes in the life of a virus: unREST in the nucleus. Cell Cycle 2005, 4:1019-1021.
53. Gu H., Liang Y., Mandel G., Roizman B. Components of the REST/coREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 21:7571-7576.
54. Everett R.D., Maul G.G. HSV-1IE protein Vmw110 causes redistribution of PML. EMBO J. 1994, 13:5062-5069.
55. Maul G.G., Guldner H.H., Spivack J.G. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 1993, 74(Pt 12):2679-2690.
56. Everett R.D., Freemont P., Saitoh H., Dasso M., Orr A., Kathoria M., Parkinson J. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 1998, 72:6581-6591.
57. Melroe G.T., Silva L., Schaffer P.A., Knipe D.M. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: potential role in blocking IFN-beta induction. Virology 2007, 360:305-321.
58. Melroe G.T., DeLuca N.A., Knipe D.M. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 2004, 78:8411-8420.
59. Mossman K.L., Saffran H.A., Smiley J.R. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 2000, 74:2052-2056.
60. Boutell C., Sadis S., Everett R.D. Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 2002, 76:841-850.
61. Chou J., Roizman B. The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:3266-3270.
62. 134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1a to dephosphorylate the a subunit of the eukaryotic initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:843-848.
63. Jin H., Ma Y., Prabhakar B.S., Feng Z., Valyi-Nagy T., Yan Z., Verpooten D., Zhang C., Cao Y., He B. The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection. J. Virol. 2009, 83:4984-4994.
64. 134.5 protein of herpes simplex virus 1. J. Biol. Chem. 2009, 284:1097-1105.
65. Orvedahl A., Alexander D., Talloczy Z., Sun Q., Wei Y., Zhang W., Burns D., Leib D.A., Levine B. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 2007, 1:23-35.
66. Leib D.A., Alexander D.E., Cox D., Yin J., Ferguson T.A. Interaction of ICP34.5 with Beclin 1 modulates herpes simplex virus type 1 pathogenesis through control of CD4+ T-cell responses. J. Virol. 2009, 83:12164-12171.
67. Trgovcich J., Johnson D., Roizman B. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1. J. Virol. 2002, 76:6974-6986.
68. Bryant K.F., Cox J.C., Wang H., Hogle J.M., Coen D.M. Binding of herpes simplex virus-1 US11 to specific RNA sequences. Nucleic Acids Res. 2005, 33:6090-6100.
69. 134.5 gene if present before activation of protein kinase R by precluding its phosphorylation and that of the α subunit of eukaryotic initiation factor 2. J. Virol. 1998, 72:8620-8626.
70. 134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF2α. J. Virol. 1998, 72:7005-7011.
71. Mulvey M., Camarena V., Mohr I. Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and gamma(1)34.5 gene products. J. Virol. 2004, 78:10193-10196.
72. Poppers J., Mulvey M., Khoo D., Mohr I. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J. Virol. 2000, 74:11215-11221.
73. Stevens J.G., Wagner E.K., Devi-Rao G.B., Cook M.L., Feldman L.T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 1987, 235:1056-1059.
74. Dobson A.T., Sederati F., Devi-Rao G., Flanagan W.M., Farrell M.J., Stevens J.G., Wagner E.K., Feldman L.T. Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 1989, 63:3844-3851.
75. Farrell M.J., Dobson A.T., Feldman L.T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:790-794.
76. Chen S.-H., Kramer M.F., Schaffer P.A., Coen D.M. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 1997, 71:5878-5884.
77. Cliffe A.R., Garber D.A., Knipe D.M. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J. Virol. 2009, 83:8182-8190.
78. Garber D.A., Schaffer P.A., Knipe D.M. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J. Virol. 1997, 71:5885-5893.
79. Perng G.-C., Jones C., Ciacci-Zanella J., Stone M., Henderson G., Yukht A., Slanina S.M., Hofman F.M., Ghiasi H., Nesburn A.B., Wechsler S.L. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000, 287:1500-1503.
80. Thompson R.L., Sawtell N.M. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. 2001, 75:6660-6675.
81. Wang Q.Y., Zhou C., Johnson K.E., Colgrove R.C., Coen D.M., Knipe D.M. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16055-16059.
82. Saini H.K., Enright A.J., Griffiths-Jones S. Annotation of mammalian primary microRNAs. BMC Genomics 2008, 9:564.
83. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., Barbisin M., Xu N.L., Mahuvakar V.R., Andersen M.R., Lao K.Q., Livak K.J., Guegler K.J. Realtime quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33:e179.
84. Linsen S.E.V., de Wit E., Jansens G., Heater S., Chapman L., Parkin R.F., Fritz B., Wyman S.K., de Bruijn E., Voest E.E., Kuersten S., Tewarie M., Cuppen E. Limitations and possibilities of small RNA digital gene expression profiling. Nat. Methods 2009, 6:474-476.
85. M.F. Kramer, I. Jurak, J.M. Pesola, S. Boissel, D.M. Knipe, D.M. Coen, Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia, Virology accepted for publication (2011).
86. Spivack J.G., Fraser N.W. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J. Virol. 1987, 61:3841-3847.
87. Chen S.-H., Lee L.Y., Garber D.A., Schaffer P.A., Knipe D.M., Coen D.M. Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J. Virol. 2002, 76:4764-4772.
88. Kramer M.F., Chen S.-H., Knipe D.M., Coen D.M. Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J. Virol. 1998, 72:1177-1185.
89. Kramer M.F., Coen D.M. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 1995, 69:1389-1399.
90. Pesola J.M., Zhu J., Knipe D.M., Coen D.M. Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production. J. Virol. 2005, 79:14516-14525.
91. Tal-Singer R., Lasner T.M., Podrzucki W., Skokotas A., Leary J.J., Berger S.L., Fraser N.W. Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J. Virol. 1997, 71:5268-5276.
92. Ben-Hur T., Moyal M., Rösen-Wolfe A., Darai G., Becker Y. Characterization of RNA transcripts from herpes simplex virus-1 DNA fragment BamHI-B. Virology 1989, 169:1-8.
93. L junction. Virology 1993, 196:220-231.
94. Zhu J., Kang W., Marquart M.E., Hill J.M., Zheng X., Block T.M., Fraser N.W. Identification of a novel 0.7-kb polyadenylated transcript in the LAT promoter region of HSV-1 that is strain specific and may contribute to virulence. Virology 1999, 265:296-307.
95. Naito J., Mukerjee R., Mott K.R., Kang W., Osorio N., Fraser N.W., Perng G.C. Identification of a protein encoded in the herpes simplex virus type 1 latency associated transcript promoter region. Virus Res. 2005, 108:101-110.
96. Tang S., Bertke A.S., Patel A., Margolis T.P., Krause P.R. Herpes simplex virus 2 microRNA miR-H6 is a novel latency-associated transcript-associated microRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype. J. Virol. 2011, 85:4501-4509.
97. Perng G.C., Maguen B., Jin L., Mott K.R., Kurylo J., BenMohamed L., Yukht A., Osorio N., Nesburn A.B., Henderson G., Inman M., Jones C., Wechsler S.L. A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits. J. Virol. 2002, 76:8003-8010.
98. Berretta J., Morillon A. Pervasive transcription constitutes a new level of eukaryotic genome regulation. EMBO Rep. 2009, 10:973-982.
99. Han J., Lee Y., Yeom K.H., Nam J.W., Heo I., Rhee J.K., Sohn S.Y., Cho Y., Zhang B.T., Kim V.N. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006, 125:887-901.
100. Ambros V., Bartel B., Bartel D.P., Burge C.B., Carrington J.C., Chen X., Dreyfuss G., Eddy S.R., Griffiths-Jones S., Marshall M., Matzke M., Ruvkun G., Tuschl T. A uniform system for microRNA annotation. RNA 2003, 9:277-279.
101. Bludau H., Freese U.K. Analysis of the HSV-1 strain 17 DNA polymerase gene reveals the expression of four different classes of pol transcripts. Virology 1991, 183:505-518.
102. Hubenthal-Voss J., Starr L., Roizman B. The herpes simplex virus origins of DNA synthesis in the S component are each contained in a transcribed open reading frame. J. Virol. 1987, 61:3349-3355.
103. Yager D.R., Coen D.M. Analysis of the transcript of the herpes simplex virus DNA polymerase gene provides evidence that polymerase expression is inefficient at the level of translation. J. Virol. 1988, 62:2007-2015.
104. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
105. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
106. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human microRNA targets. PLoS Biol. 2004, 2:e363.
107. Thomas M., Lieberman J., Lal A. Desperately seeking microRNA targets. Nat. Struct. Mol. Biol. 2010, 17:1169-1174.
108. Skalsky R.L., Cullen B.R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 2010, 64:123-141.
109. Zeng Y., Cullen B.R. RNA interference in human cells is restricted to the cytoplasm. RNA 2002, 8:855-860.
110. Hwang H.W., Wentzel E.A., Mendell J.T. A hexanucleotide element directs microRNA nuclear import. Science 2007, 315:97-100.
111. Castanotto D., Lingeman R., Riggs A.D., Rossi J.J. CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21655-21659.
112. Jeffries C.D., Fried H.M., Perkins D.O. Nuclear and cytoplasmic localization of neural stem cell microRNAs. RNA 2011.
113. Tyler D.M., Okamura K., Chung W.J., Hagen J.W., Berezikov E., Hannon G.J., Lai E.C. Functionally distinct regulatory RNAs generated by bidirectional transcription and processing of microRNA loci. Genes Dev. 2008, 22:26-36.
114. Buck A.H., Santoyo-Lopez J., Robertson K.A., Kumar D.S., Reczko M., Ghazal P. Discrete clusters of virus-encoded microRNAs are associated with complementary strands of the genome and the 7.2-kilobase stable intron in murine cytomegalovirus. J. Virol. 2007, 81:13761-13770.
115. Lai E.C., Wiel C., Rubin G.M. Complementary miRNA pairs suggest a regulatory role for miRNA:miRNA duplexes. RNA 2004, 10:171-175.
116. Dolken L., Pfeffer S., Koszinowski U.H. Cytomegalovirus microRNAs. Virus Genes 2009, 38:355-364.
117. Maillet S., Naas T., Crepin S., Roque-Afonso A.M., Lafay F., Efstathiou S., Labetoulle M. Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts. J. Virol. 2006, 80:9310-9321.
118. Whitley R.J., Kern E.R., Chatterjee S., Chou J., Roizman B. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J. Clinical Invest. 1993, 91:2837-2843.
119. Chou J., Kern E.R., Whitley R.J., Roizman B. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 1990, 250:1262-1266.
120. Bolovan C.A., Sawtell N.M., Thompson R.L. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J. Virol. 1994, 68:48-55.
121. Schwarz D.S., Hutvagner G., Du T., Xu Z., Aronin N., Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115:199-208.
122. Khvorova A., Reynolds A., Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
123. Yang J.S., Phillips M.D., Betel D., Mu P., Ventura A., Siepel A.C., Chen K.C., Lai E.C. Widespread regulatory activity of vertebrate microRNA* species. RNA 2011, 17:312-326.
124. Otsuka M., Jing Q., Georgel P., New L., Chen J., Mols J., Kang Y.J., Jiang Z., Du X., Cook R., Das S.C., Pattnaik A.K., Beutler B., Han J. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007, 27:123-134.
125. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saib A., Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308:557-560.
126. Wang F.Z., Weber F., Croce C., Liu C.G., Liao X., Pellett P.E. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J. Virol. 2008, 82:9065-9074.
127. Buck A.H., Perot J., Chisholm M.A., Kumar D.S., Tuddenham L., Cognat V., Marcinowski L., Dolken L., Pfeffer S. Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA 2010, 16:307-315.
128. Ramachandran V., Chen X. Degradation of microRNAs by a family of exoribonucleases in Arabidopsis. Science 2008, 321:1490-1492.
129. Chatterjee S., Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 2009, 461:546-549.
130. Ibrahim F., Rymarquis L.A., Kim E.J., Becker J., Balassa E., Green P.J., Cerutti H. Uridylation of mature miRNAs and siRNAs by the MUT68 nucleotidyltransferase promotes their degradation in Chlamydomonas. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3906-3911.
131. Ibrahim F., Rohr J., Jeong W.J., Hesson J., Cerutti H. Untemplated oligoadenylation promotes degradation of RISC-cleaved transcripts. Science 2006, 314:1893.
132. Bivalkar-Mehla S., Vakharia J., Mehla R., Abreha M., Kanwar J.R., Tikoo A., Chauhan A. Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system. Virus Res. 2011, 155:1-9.
133. Lu S., Cullen B.R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J. Virol. 2004, 78:12868-12876.
134. Andersson M.G., Haasnoot P.C., Xu N., Berenjian S., Berkhout B., Akusjarvi G. Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol. 2005, 79:9556-9565.
135. Xu N., Segerman B., Zhou X., Akusjarvi G. Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the RNA-induced silencing complex and associate with polyribosomes. J. Virol. 2007, 81:10540-10549.
136. Taddeo B., Roizman B. The virion host shutoff protein (UL41) of herpes simplex virus 1 is an endoribonuclease with a substrate specificity similar to that of RNase A. J. Virol. 2006, 80:9341-9345.
137. Taddeo B., Zhang W., Roizman B. The U(L)41 protein of herpes simplex virus 1 degrades RNA by endonucleolytic cleavage in absence of other cellular or viral proteins. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2827-2832.
138. Wang X., Wang H.K., McCoy J.P., Banerjee N.S., Rader J.S., Broker T.R., Meyers C., Chow L.T., Zheng Z.M. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 2009, 15:637-647.
139. Kang J.G., Pripuzova N., Majerciak V., Kruhlak M., Le S.Y., Zheng Z.M. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J. Virol. 2011, 85:2620-2630.
140. Hill J.M., Zhao Y., Clement C., Neumann D.M., Lukiw W.J. HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling. Neuroreport 2009, 20:1500-1505.
141. Wu Z., Zhu Y., Bisaro D.M., Parris D.S. Herpes simplex virus type 1 suppresses RNA-induced gene silencing in mammalian cells. J. Virol. 2009, 83:6652-6663.
142. Whitley R.J., Hilliard J. Cercopithecine Herpes Virus 1 (B virus). Fields Virology 2007, vol. 2:2889-2903. Lippincott Williams & Wilkins, Philadelphia, PA.
143. Cohen J.I., Davenport D.S., Stewart J.A., Deitchman S., Hilliard J.K., Chapman L.E. Recommendations for prevention of and therapy for exposure to B virus. Clin. Infect. Dis. 2002, 35:1191-1203.
144. Bryan B.L., Espana C.D., Emmons R.W., Vijayan N., Hoeprich P.D. Recovery from encephalomyelitis caused by Herpesvirus simiae. Report of a case. Arch. Intern. Med. 1975, 135:868-870.
145. Holmes G.P., Hilliard J.K., Klontz K.C., Rupert A.H., Schindler C.M., Parrish E., Griffin D.G., Ward G.S., Bernstein N.D., Bean T.W., et al. B virus (Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann. Intern. Med. 1990, 112:833-839.
146. Perelygina L., Zhu L., Zurkuhlen H., Mills R., Borodovsky M., Hilliard J.K. Complete sequence and comparative analysis of the genome of herpes B virus (Cercopithecine herpesvirus 1) from a rhesus monkey. J. Virol. 2003, 77:6167-6177.
147. Barth S., Pfuhl T., Mamiani A., Ehses C., Roemer K., Kremmer E., Jaker C., Hock J., Meister G., Grasser F.A. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 2008, 36:666-675.
148. Grinfeld E., Kennedy P.G. Translation of varicella-zoster virus genes during human ganglionic latency. Virus Genes 2004, 29:317-319.
149. Davis N., Biddlecom N., Hecht D., Fogel G.B. On the relationship between GC content and the number of predicted microRNA binding sites by MicroInspector. Comput. Biol. Chem. 2008, 32:222-226.
150. Bowland S.L., Shewen P.E. Bovine respiratory disease: commercial vaccines currently available in Canada. Can. Vet. J. 2000, 41:33-48.
151. Jones C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin. Microbiol. Rev. 2003, 16:79-95.
152. Tikoo S.K., Campos M., Babiuk L.A. Bovine herpesvirus 1 (BHV-1): biology, pathogenesis, and control. Adv. Virus Res. 1995, 45:191-223.
153. Jones C., Geiser V., Henderson G., Jiang Y., Meyer F., Perez S., Zhang Y. Functional analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency. Vet. Microbiol. 2006, 113:199-210.
154. Aujeszky A. Ueber eine neue Infektionskrankheit bei Hautieren. Zentralblatt Bakteriologie 1902, 32:353-357.
155. Stallknecht D.E., Howerth E.W. Pseudorabies (Aujeszky's disease). Infectious Diseases of Wild Mammals 2001, 164-170. Blackwell Publishing, Ames. E.S. Williams, I.K. Barker (Eds.).
156. Pomeranz L.E., Reynolds A.E., Hengartner C.J. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol. Mol. Biol. Rev. 2005, 69:462-500.